{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:39:33Z","timestamp":1770496773898,"version":"3.49.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.soc.2023.05.004","type":"journal-article","created":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T07:02:12Z","timestamp":1687676532000},"page":"705-724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Managing the Morbidity"],"prefix":"10.1016","volume":"32","author":[{"given":"Giacomo","family":"Montagna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea V.","family":"Barrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.soc.2023.05.004_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A\u00a0randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.soc.2023.05.004_bib2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.soc.2023.05.004_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.soc.2023.05.004_bib4","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.22.01565","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial","volume":"41","author":"Bartels","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.soc.2023.05.004_bib5","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.soc.2023.05.004_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol"},{"issue":"29","key":"10.1016\/j.soc.2023.05.004_bib7","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1200\/JCO.20.00459","article-title":"Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial","volume":"38","author":"Naoum","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"24","key":"10.1016\/j.soc.2023.05.004_bib8","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"32","key":"10.1016\/j.soc.2023.05.004_bib9","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","article-title":"Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements","volume":"26","author":"McLaughlin","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"20","key":"10.1016\/j.soc.2023.05.004_bib10","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMcp1803290","article-title":"Lymphedema after breast cancer treatment","volume":"379","author":"Rockson","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.soc.2023.05.004_bib11","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1200\/JCO.21.01681","article-title":"Prospective surveillance for breast cancer-related arm lymphedema: a systematic review and meta-analysis","volume":"40","author":"Rafn","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2023.05.004_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11764-012-0247-5","article-title":"Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes","volume":"7","author":"Pusic","year":"2013","journal-title":"J\u00a0Cancer Surviv"},{"issue":"3","key":"10.1016\/j.soc.2023.05.004_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5306\/wjco.v5.i3.241","article-title":"Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management","volume":"5","author":"Fu","year":"2014","journal-title":"World J Clin Oncol"},{"issue":"7","key":"10.1016\/j.soc.2023.05.004_bib14","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/tbj.13750","article-title":"Trends in utilization of sentinel node biopsy and adjuvant radiation in women \u2265 70","volume":"26","author":"Gunn","year":"2020","journal-title":"Breast J"},{"issue":"8","key":"10.1016\/j.soc.2023.05.004_bib15","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jamaoncol.2022.1628","article-title":"Risk factors and racial and ethnic disparities in patients with breast cancer-related lymphedema","volume":"8","author":"Montagna","year":"2022","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.soc.2023.05.004_bib16","first-page":"170","article-title":"The Diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the international society of lymphology","volume":"49","author":"Executive","year":"2016","journal-title":"Lymphology"},{"issue":"14","key":"10.1016\/j.soc.2023.05.004_bib17","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.soc.2023.05.004_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.soc.2023.05.004_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10549-016-4089-0","article-title":"Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis","volume":"162","author":"Shaitelman","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"10.1016\/j.soc.2023.05.004_bib20","first-page":"1878","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.soc.2023.05.004_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10549-013-2715-7","article-title":"Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer","volume":"142","author":"Jammallo","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.soc.2023.05.004_bib22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/jan.15005","article-title":"Breast cancer-related lymphoedema: Risk factors and prediction model","volume":"78","author":"Martinez-Jaimez","year":"2022","journal-title":"J\u00a0Adv Nurs"},{"issue":"9","key":"10.1016\/j.soc.2023.05.004_bib23","first-page":"5435","article-title":"Development and validation of a nomogram to predict the risk of breast cancer-related lymphedema among Chinese breast cancer survivors","volume":"29","author":"Liu","year":"2021","journal-title":"Support Care Cancer"},{"issue":"11","key":"10.1016\/j.soc.2023.05.004_bib24","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jamaoncol.2019.2109","article-title":"Effect of home-based exercise and weight loss programs on breast cancer-related lymphedema outcomes among overweight breast cancer survivors: the WISER survivor randomized clinical trial","volume":"5","author":"Schmitz","year":"2019","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.soc.2023.05.004_bib25","first-page":"269","article-title":"The effect of docetaxel on developing oedema in patients with breast cancer: a systematic review","volume":"25","author":"Hugenholtz-Wamsteker","year":"2016","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.soc.2023.05.004_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.breast.2016.04.011","article-title":"Risk factors for lymphoedema in women with breast cancer: a large prospective cohort","volume":"28","author":"Kilbreath","year":"2016","journal-title":"Breast"},{"issue":"3","key":"10.1016\/j.soc.2023.05.004_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/CAD.0000000000000468","article-title":"Association between adjuvant docetaxel-based chemotherapy and breast cancer-related lymphedema","volume":"28","author":"Zhu","year":"2017","journal-title":"Anti Cancer Drugs"},{"issue":"2","key":"10.1016\/j.soc.2023.05.004_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10549-015-3408-1","article-title":"Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort","volume":"151","author":"Swaroop","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"13","key":"10.1016\/j.soc.2023.05.004_bib29","doi-asserted-by":"crossref","first-page":"8624","DOI":"10.1245\/s10434-021-10173-0","article-title":"Subclinical lymphedema after treatment for breast cancer: risk of progression and considerations for early intervention","volume":"28","author":"Bucci","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.soc.2023.05.004_bib30","doi-asserted-by":"crossref","first-page":"8634","DOI":"10.1245\/s10434-021-10176-x","article-title":"ASO author reflections: the promising potential of early intervention for subclinical lymphedema in women who underwent nodal surgery for breast cancer","volume":"28","author":"Bucci","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"10.1016\/j.soc.2023.05.004_bib31","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1002\/cncr.34489","article-title":"Burden of lymphedema in long-term breast cancer survivors by race and age","volume":"128","author":"Ren","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2023.05.004_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-med-060116-022900","article-title":"Lymphedema: pathogenesis and novel therapies","volume":"69","author":"Dayan","year":"2018","journal-title":"Annu Rev Med"},{"issue":"8","key":"10.1016\/j.soc.2023.05.004_bib33","doi-asserted-by":"crossref","first-page":"e0182791","DOI":"10.1371\/journal.pone.0182791","article-title":"Evidence of selection as a cause for racial disparities in fibroproliferative disease","volume":"12","author":"Hellwege","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.soc.2023.05.004_bib34","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1096\/fj.12-222695","article-title":"Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema","volume":"27","author":"Avraham","year":"2013","journal-title":"FASEB J"},{"issue":"9","key":"10.1016\/j.soc.2023.05.004_bib35","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1158\/1078-0432.CCR-15-2239","article-title":"Systemic correlates of white adipose tissue inflammation in early-stage breast cancer","volume":"22","author":"Iyengar","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.soc.2023.05.004_bib36","series-title":"Does breast inflammation contribute to lymphedema risk in patients treated with haxillary lymph node dissection?","author":"Barrio","year":"2022"},{"issue":"1","key":"10.1016\/j.soc.2023.05.004_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10549-014-3137-x","article-title":"Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II\/III breast cancer patients","volume":"148","author":"Jung","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.soc.2023.05.004_bib38","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4143\/crt.2014.079","article-title":"Breast cancer-related lymphedema after neoadjuvant chemotherapy","volume":"47","author":"Kim","year":"2015","journal-title":"Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.soc.2023.05.004_bib39","first-page":"495","article-title":"Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy","volume":"27","author":"Armer","year":"2019","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.soc.2023.05.004_bib40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijrobp.2013.11.232","article-title":"The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study","volume":"88","author":"Warren","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.soc.2023.05.004_bib41","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1245\/s10434-012-2290-x","article-title":"Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer","volume":"19","author":"Bevilacqua","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2023.05.004_bib42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/SLA.0000000000002373","article-title":"Tumor biology and response to chemotherapy impact breast cancer-specific survival in node-positive breast cancer patients treated with neoadjuvant chemotherapy: long-term follow-up from ACOSOG Z1071 (Alliance)","volume":"266","author":"Boughey","year":"2017","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.soc.2023.05.004_bib43","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1245\/s10434-020-08650-z","article-title":"Selecting node-positive patients for axillary downstaging with neoadjuvant chemotherapy","volume":"27","author":"Montagna","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"25","key":"10.1016\/j.soc.2023.05.004_bib44","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.soc.2023.05.004_bib45","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1245\/s10434-022-12142-7","article-title":"Lymphedema in inflammatory breast cancer patients following trimodal treatment","volume":"29","author":"Farley","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2023.05.004_bib46","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.1999.17.2.460","article-title":"Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy","volume":"17","author":"Kuerer","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2023.05.004_bib47","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.soc.2023.05.004_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(11)70336-9","article-title":"Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial","volume":"13","author":"Gianni","year":"2012","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.soc.2023.05.004_bib49","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S1470-2045(18)30570-9","article-title":"Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial","volume":"19","author":"van Ramshorst","year":"2018","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.soc.2023.05.004_bib50","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/annonc\/mdt182","article-title":"Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)","volume":"24","author":"Schneeweiss","year":"2013","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.soc.2023.05.004_bib51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1470-2045(18)30111-6","article-title":"Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial","volume":"19","author":"Loibl","year":"2018","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.soc.2023.05.004_bib52","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for Early Triple-Negative Breast Cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2023.05.004_bib53","unstructured":"Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03255577. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer. Accessed December 15, 2022."},{"key":"10.1016\/j.soc.2023.05.004_bib54","unstructured":"Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05462457. TAD in Primary Breast Cancer With Initially \u2265 3 Suspicious Lymph Nodes (SenTa 2). Accessed December 12, 2022."},{"issue":"1","key":"10.1016\/j.soc.2023.05.004_bib55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijrobp.2018.08.036","article-title":"Timing of lymphedema after treatment for breast cancer: when are patients most at risk?","volume":"103","author":"McDuff","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.soc.2023.05.004_bib56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/jpm5020153","article-title":"Establishing and sustaining a prospective screening program for breast cancer-related lymphedema at the massachusetts general hospital: lessons learned","volume":"5","author":"Brunelle","year":"2015","journal-title":"J\u00a0Personalized Med"},{"issue":"12","key":"10.1016\/j.soc.2023.05.004_bib57","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/cncr.23494","article-title":"Preoperative assessment enables the early diagnosis and successful treatment of lymphedema","volume":"112","author":"Stout Gergich","year":"2008","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.soc.2023.05.004_bib58","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1245\/s10434-017-5982-4","article-title":"Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: recommendations from a multidisciplinary expert ASBrS Panel : part 1: definitions, assessments, education, and future directions","volume":"24","author":"McLaughlin","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.soc.2023.05.004_bib59","unstructured":"National Lymphedema Network. Position paper: The diagnosis and treatment of lymphedema. https:\/\/lymphnet.org\/position-papers. Accessed June 9, 2023."},{"issue":"1","key":"10.1016\/j.soc.2023.05.004_bib60","first-page":"1","article-title":"The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology","volume":"46","author":"International Society of","year":"2013","journal-title":"Lymphology"},{"key":"10.1016\/j.soc.2023.05.004_bib61","unstructured":"Available at: https:\/\/oncolife.com.ua\/doc\/nccn\/Survivorship.pdf. Freedman-Cass. D, McMillian N, Baker SK, et\u00a0al: NCCN Clinical Practice Guidelines in Oncology (NCCN Guideline): Version 3.2017 Survivorship. Accessed June 9, 2023."},{"issue":"2","key":"10.1016\/j.soc.2023.05.004_bib62","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1245\/s10434-021-10645-3","article-title":"Diagnostic criteria for breast cancer-related lymphedema of the upper extremity: the need for universal agreement","volume":"29","author":"Kassamani","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2023.05.004_bib63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10549-012-2111-8","article-title":"Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology","volume":"135","author":"Ancukiewicz","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.soc.2023.05.004_bib64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-016-3821-0","article-title":"The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema","volume":"157","author":"Sun","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"32","key":"10.1016\/j.soc.2023.05.004_bib65","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1200\/JCO.2008.16.3766","article-title":"Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors","volume":"26","author":"McLaughlin","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2023.05.004_bib66","article-title":"Longitudinal prospective evaluation of quality of life after axillary lymph node dissection","author":"Zhang","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2023.05.004_bib67","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/lrb.2017.0070","article-title":"A\u00a0prospective study of l-dex values in breast cancer patients pretreatment and through 12\u00a0months postoperatively","volume":"16","author":"Ridner","year":"2018","journal-title":"Lymphatic Res Biol"},{"issue":"6","key":"10.1016\/j.soc.2023.05.004_bib68","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/lrb.2021.0084","article-title":"A\u00a0comparison of bioimpedance spectroscopy or tape measure triggered compression intervention in chronic breast cancer lymphedema prevention","volume":"20","author":"Ridner","year":"2022","journal-title":"Lymphatic Res Biol"},{"issue":"Suppl 3","key":"10.1016\/j.soc.2023.05.004_bib69","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1245\/s10434-019-07763-4","article-title":"Letter to Editor re: Ridner et\u00a0al.: \"A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis\"","volume":"26","author":"Barrio","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2023.05.004_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2458\/lymph.4677","article-title":"Comparison of perometry-based volumetric arm measurements and bioimpedance spectroscopy for early identification of lymphedema in a prospectively-screened cohort of breast cancer patients","volume":"54","author":"Gillespie","year":"2021","journal-title":"Lymphology"},{"key":"10.1016\/j.soc.2023.05.004_bib71","unstructured":"Diskin B, Axelrod B, Sevilimedu V, et\u00a0al. Diagnosing Lymphedema after Axillary Surgery: Which Method is Superior? 2023 Society of Surgical Oncology Annual Meeting 2023; Boston, MA."},{"issue":"6","key":"10.1016\/j.soc.2023.05.004_bib72","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9","article-title":"Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis","volume":"92","author":"Petrek","year":"2001","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.soc.2023.05.004_bib73","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1245\/s10434-010-1155-4","article-title":"Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema","volume":"17","author":"Goldberg","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"21","key":"10.1016\/j.soc.2023.05.004_bib74","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1002\/cncr.33819","article-title":"Weight loss does not decrease risk of breast cancer-related arm lymphedema","volume":"127","author":"Roberts","year":"2021","journal-title":"Cancer"},{"issue":"24","key":"10.1016\/j.soc.2023.05.004_bib75","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/jnci\/djj494","article-title":"Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study","volume":"98","author":"Chlebowski","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"35","key":"10.1016\/j.soc.2023.05.004_bib76","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1200\/JCO.2016.69.4026","article-title":"Weight loss randomized intervention trials in female cancer survivors","volume":"34","author":"Chlebowski","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2023.05.004_bib77","first-page":"CD009765","article-title":"Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy","author":"Stuiver","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"18","key":"10.1016\/j.soc.2023.05.004_bib78","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1200\/JCO.21.02567","article-title":"Prophylactic use of compression sleeves reduces the incidence of arm swelling in women at high risk of breast cancer-related lymphedema: a randomized controlled trial","volume":"40","author":"Paramanandam","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.soc.2023.05.004_bib79","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa0810118","article-title":"Weight lifting in women with breast-cancer-related lymphedema","volume":"361","author":"Schmitz","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.soc.2023.05.004_bib80","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1001\/jama.2010.1837","article-title":"Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial","volume":"304","author":"Schmitz","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.soc.2023.05.004_bib81","doi-asserted-by":"crossref","first-page":"e066542","DOI":"10.1136\/bmj-2021-066542","article-title":"Exercise versus usual care after non-reconstructive breast cancer surgery (UK PROSPER): multicentre randomised controlled trial and economic evaluation","volume":"375","author":"Bruce","year":"2021","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.soc.2023.05.004_bib82","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1245\/s10434-007-9412-x","article-title":"Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation","volume":"14","author":"Thompson","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.soc.2023.05.004_bib83","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1245\/s10434-008-0030-z","article-title":"Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection","volume":"15","author":"Nos","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2023.05.004_bib84","doi-asserted-by":"crossref","first-page":"e0150285","DOI":"10.1371\/journal.pone.0150285","article-title":"The feasibility and oncological safety of axillary reverse mapping in patients with breast cancer: a systematic review and meta-analysis of prospective studies","volume":"11","author":"Han","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.soc.2023.05.004_bib85","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/bjs.10041","article-title":"Systematic review of axillary reverse mapping in breast cancer","volume":"103","author":"Ahmed","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.soc.2023.05.004_bib86","unstructured":"Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT03927027. Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection. Accessed January 8, 2023."},{"issue":"9","key":"10.1016\/j.soc.2023.05.004_bib87","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1245\/s10434-011-1624-4","article-title":"Surgical prevention of arm lymphedema after breast cancer treatment","volume":"18","author":"Boccardo","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2023.05.004_bib88","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/micr.22254","article-title":"Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up","volume":"34","author":"Boccardo","year":"2014","journal-title":"Microsurgery"},{"issue":"2","key":"10.1016\/j.soc.2023.05.004_bib89","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jso.25513","article-title":"Axillary reverse mapping and lymphaticovenous bypass: Lymphedema prevention through enhanced lymphatic visualization and restoration of flow","volume":"120","author":"Schwarz","year":"2019","journal-title":"J\u00a0Surg Oncol"},{"issue":"10","key":"10.1016\/j.soc.2023.05.004_bib90","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1245\/s10434-015-4721-y","article-title":"Single Institution experience with lymphatic microsurgical preventive healing approach (LYMPHA) for the primary prevention of lymphedema","volume":"22","author":"Feldman","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2023.05.004_bib91","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/SLA.0000000000002827","article-title":"Evaluation of simplified lymphatic microsurgical preventing healing approach (S-LYMPHA) for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection","volume":"270","author":"Ozmen","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2023.05.004_bib92","unstructured":"Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04241341. Does immediate lymphatic reconstruction decrease the risk of lymphedema after axillary lymph node dissection. Accessed January 8, 2023."},{"issue":"2","key":"10.1016\/j.soc.2023.05.004_bib93","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/B:BREA.0000032978.67677.9f","article-title":"The addition of manual lymph drainage to compression therapy for breast cancer related lymphedema: a randomized controlled trial","volume":"86","author":"McNeely","year":"2004","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.soc.2023.05.004_bib94","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/s-0042-1744414","article-title":"Optimizing treatment of breast cancer related lymphedema using combined DIEP flap and lymphedema Surgery","volume":"49","author":"Chang","year":"2022","journal-title":"Arch Plast Surg"},{"issue":"5\u20136","key":"10.1016\/j.soc.2023.05.004_bib95","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10585-018-9897-7","article-title":"Lymphedema surgery: the current state of the art","volume":"35","author":"Granzow","year":"2018","journal-title":"Clin Exp Metastasis"},{"issue":"5","key":"10.1016\/j.soc.2023.05.004_bib96","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jso.25180","article-title":"Lymph node transplantation for the treatment of lymphedema","volume":"118","author":"Gould","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2023.05.004_bib97","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/SLA.0000000000005591","article-title":"A\u00a0prospective study on the safety and efficacy of vascularized lymph node transplant","volume":"276","author":"Brown","year":"2022","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.soc.2023.05.004_bib98","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1245\/s10434-015-4408-4","article-title":"An algorithmic approach to simultaneous vascularized lymph node transfer with microvascular breast reconstruction","volume":"22","author":"Nguyen","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2023.05.004_bib99","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/SLA.0b013e3182426757","article-title":"Microvascular breast reconstruction and lymph node transfer for postmastectomy lymphedema patients","volume":"255","author":"Saaristo","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2023.05.004_bib100","unstructured":"Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03248310. A study comparing quality of life in patients with lymphedema who undergo surgical treatment versus non-surgical management. Accessed June 9, 2023."},{"issue":"11","key":"10.1016\/j.soc.2023.05.004_bib101","first-page":"e19813","article-title":"Noninvasive measurements of breast cancer-related lymphedema","volume":"13","author":"Mayrovitz","year":"2021","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.soc.2023.05.004_bib102","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/lrb.2005.3.208","article-title":"A\u00a0comparison of four diagnostic criteria for lymphedema in a post-breast cancer population","volume":"3","author":"Armer","year":"2005","journal-title":"Lymphatic Res Biol"},{"issue":"4","key":"10.1016\/j.soc.2023.05.004_bib103","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.apmr.2010.11.017","article-title":"Comparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: area under the curve","volume":"92","author":"Smoot","year":"2011","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"10.1016\/j.soc.2023.05.004_bib104","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/jpm5040341","article-title":"Measurement issues in anthropometric measures of limb volume change in persons at risk for and living with lymphedema: a reliability study","volume":"5","author":"Tidhar","year":"2015","journal-title":"J\u00a0Personalized Med"},{"key":"10.1016\/j.soc.2023.05.004_bib105","unstructured":"Available at: https:\/\/www.impedimed.com. ImpediMed: SOZO App and System instructions for use. Accessed January 11, 2023."},{"issue":"2","key":"10.1016\/j.soc.2023.05.004_bib106","first-page":"77","article-title":"Validation of an optoelectronic limb volumeter (Perometer)","volume":"30","author":"Stanton","year":"1997","journal-title":"Lymphology"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105532072300042X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105532072300042X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:07:28Z","timestamp":1760962048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105532072300042X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S105532072300042X"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2023.05.004","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing the Morbidity","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2023.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}